Yanting Yang
Nanning, 530016, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
mTOR Signaling Pathway in Antiphospholipid Syndrome: Pathogenesis and Potential Therapeutic Targets.
mTOR Signaling Pathway in Antiphospholipid Syndrome: Pathogenesis and Potential Therapeutic Targets.
Journal: Drug design, development and therapy
Published: December 25, 2025
mTOR signaling pathway in primary Sjögren's syndrome: Pathogenesis and potential therapeutic targets (Review).
Journal: International journal of molecular medicine
Published: October 23, 2025
Mortality associated with systemic lupus erythematosus combined with heart failure in the United States (1999-2020): A multiple-cause-of-death study.
Journal: Medicine
Published: May 26, 2025
Analysis of related deaths in patients with systemic sclerosis combined with renal failure in the United States from 1999 to 2020.
Journal: Scientific reports
Published: December 16, 2024
Role of monocytes in the pathogenesis of antiphospholipid syndrome and potential therapeutic targets (Review).
Journal: Molecular medicine reports
Published: October 14, 2024
Hydroxychloroquine: A double‑edged sword (Review).
Journal: Molecular medicine reports
Published: September 19, 2024
Vitamin D affects antiphospholipid syndrome by regulating T cells (Review).
Journal: International journal of molecular medicine
Published: August 28, 2024
Mortality associated with osteoporosis and pathological fractures in the United States (1999-2020): a multiple-cause-of-death study.
Journal: Journal of orthopaedic surgery and research
Published: July 12, 2024
Potential of resveratrol in the treatment of systemic lupus erythematosus (Review).
Journal: Molecular medicine reports
Published: December 15, 2023
Preliminary nomogram model for predicting irreversible organ damage of patients with systemic sclerosis.
Journal: Rheumatology (Oxford, England)
Published: October 25, 2023
NIR-II photoacoustic imaging-guided synergistic cancer therapy with a tumor-targeting copper selenide-iron manganese layered double hydroxide nanocomplex.
Journal: Chemical communications (Cambridge, England)
Published: September 04, 2023
Last Updated: 09/26/2026